Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|April 21, 2025
Defining long-term survivors in metastatic lung cancer: insights from a Delphi study in SpainEnric Carcereny, Manuel Domine, Ana Laura Ortega Granados
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2008
Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)Enric Carcereny Costa, Núria Viñolas Segarra, Pere Gascón Vilaplana
International Journal of Molecular Sciences|December 24, 2021
Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?Andrea Plaja, Teresa Moran, Enric Carcereny, et al.
Frontiers in Oncology|January 31, 2022
Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic StrategiesMarc Cucurull, Lucia Notario, Montse Sanchez-Cespedes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 17, 2010
Non-small-cell lung cancer harbouring mutations in the EGFR kinase domainRafael Rosell, Teresa Morán, Enric Carcereny, et al.
Expert Opinion on Pharmacotherapy|May 22, 2010
Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancerRafael Rosell, Teresa Moran, Santiago Viteri, et al.
Translational Respiratory Medicine|March 27, 2015
The epidermal growth factor receptor (EGRF) in lung cancerEnric Carcereny, Teresa Morán, Laia Capdevila, et al.
Pageof 11